Psychiatric and cognitive symptoms of Parkinson's disease: A life's tale

被引:0
作者
Amstutz, D. [1 ,2 ]
Sousa, M. [1 ,2 ]
Maradan-Gachet, M. E. [1 ,2 ]
Debove, I. [1 ]
Lhommee, E. [3 ]
Krack, P. [1 ]
机构
[1] Univ Bern, Univ Hosp Bern, Inselspital, Dept Neurol, Bern, Switzerland
[2] Univ Bern, Grad Sch Hlth Sci, Bern, Switzerland
[3] Univ Grenoble, CHU Grenoble Alpes, Dept Neurorehabil, Grenoble, France
关键词
Parkinson's disease; Non-motor symptoms; Behavioural changes; Neuropsychiatric symptoms; IMPULSE CONTROL DISORDERS; SUBTHALAMIC NUCLEUS STIMULATION; DOPAMINE DYSREGULATION SYNDROME; DEEP BRAIN-STIMULATION; QUALITY-OF-LIFE; NONMOTOR SYMPTOMS; NEUROPSYCHIATRIC SYMPTOMS; PREMORBID PERSONALITY; VISUAL HALLUCINATIONS; MINOR HALLUCINATIONS;
D O I
10.1016/j.neurol.2024.11.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. - Neuropsychiatric symptoms are highly prevalent in Parkinson's disease (PD) and significantly affect the quality of life of patients and their significant others. The aim of this work is to describe typical neuropsychiatric symptoms and their treatment. Methods. - This is a narrative opinion paper, illustrated by a fictional case report. The most common neuropsychiatric symptoms such as depressive symptoms, anxiety, apathy, psychotic symptoms, impulse control disorders, as well as cognitive impairment are discussed in the context of prodromal stage, early stage, fluctuations stage, post-surgical intervention, and late stage of PD. Results. - Multiple factors such as pathophysiology, dopaminergic medication, deep brain stimulation, personality traits and individual life circumstances influence neuropsychiatric symptoms. Since the complexity and causes of neuropsychiatric symptoms can change, management strategies have to be adapted and individualised throughout the disease trajectory. Discussion. - Recognising neuropsychiatric symptoms within the framework of the disease stage and identifying their potential causes is pivotal to provide adequate interventions. (c) 2024 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:265 / 283
页数:19
相关论文
共 205 条
[51]   Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial [J].
Devos, David ;
Moreau, Caroline ;
Maltete, David ;
Lefaucheur, Romain ;
Kreisler, Alexandre ;
Eusebio, Alexandre ;
Defer, Gilles ;
Ouk, Thavarak ;
Azulay, Jean-Philippe ;
Krystkowiak, Pierre ;
Witjas, Tatiana ;
Delliaux, Marie ;
Destee, Alain ;
Duhamel, Alain ;
Bordet, Regis ;
Defebvre, Luc ;
Dujardin, Kathy .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (06) :668-674
[52]   Hallucinations in Parkinson disease [J].
Diederich, Nico J. ;
Fenelon, Gilles ;
Stebbins, Glenn ;
Goetz, Christopher G. .
NATURE REVIEWS NEUROLOGY, 2009, 5 (06) :331-342
[53]   Anxiety Disorders in Parkinson's Disease: Prevalence and Risk Factors [J].
Dissanayaka, Nadeeka N. W. ;
Sellbach, Anna ;
Matheson, Sally ;
O'Sullivan, John D. ;
Silburn, Peter A. ;
Byrne, Gerard J. ;
Marsh, Rodney ;
Mellick, George D. .
MOVEMENT DISORDERS, 2010, 25 (07) :838-845
[54]   Parkinson's Disease Dementia [J].
Docherty, Mary J. ;
Burn, David J. .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2010, 10 (04) :292-298
[55]   Does subthalamic nucleus stimulation induce apathy in Parkinson's disease? [J].
Drapier, D. ;
Drapier, S. ;
Sauleau, P. ;
Haegelen, C. ;
Raoul, S. ;
Biseul, I. ;
Peron, J. ;
Lallement, F. ;
Rivier, I. ;
Reymann, J. M. ;
Edan, G. ;
Verin, M. ;
Millet, B. .
JOURNAL OF NEUROLOGY, 2006, 253 (08) :1083-1091
[56]   Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort study [J].
Drapier, Sophie ;
Eusebio, Alexandre ;
Degos, Bertrand ;
Verin, Marc ;
Durif, Franck ;
Azulay, Jean Philippe ;
Vilallet, Francois ;
Rouaud, Tiphaine ;
Moreau, Caroline ;
Defebvre, Luc ;
Fraix, Valerie ;
Tranchant, Christine ;
Andre, Karine ;
Courbon, Christine Brefel ;
Roze, Emmanuel ;
Devos, David .
JOURNAL OF NEUROLOGY, 2016, 263 (06) :1111-1119
[57]   Cognitive deficits in Parkinson's disease [J].
Dubois, B ;
Pillon, B .
JOURNAL OF NEUROLOGY, 1997, 244 (01) :2-8
[58]   Impulse control disorders in Parkinson disease: A cross-sectional study in Morocco [J].
El Otmani, H. ;
Mouni, F. Z. ;
Abdulhakeem, Z. ;
Attar, Z. ;
Rashad, L. ;
Saali, I. ;
El Moutawakil, B. ;
Rafai, M. A. ;
Slassi, I. ;
Nadifi, S. .
REVUE NEUROLOGIQUE, 2019, 175 (04) :233-237
[59]   Rivastigmine for dementia associated with Parkinson's disease [J].
Emre, M ;
Aarsland, D ;
Albanese, A ;
Byrne, EJ ;
Deuschl, G ;
De Deyn, PP ;
Durif, F ;
Kulisevsky, J ;
van Laar, T ;
Lees, A ;
Poewe, W ;
Robillard, A ;
Rosa, MM ;
Wolters, E ;
Quarg, P ;
Tekin, S ;
Lane, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24) :2509-2518
[60]   Clinical diagnostic criteria for dementia associated with Parkinson's disease [J].
Emre, Murat ;
Aarsland, Dag ;
Brown, Richard ;
Bum, David J. ;
Duyckaerts, Charles ;
Mizuno, Yoshikino ;
Broe, Gerald Anthony ;
Cummings, Jeffrey ;
Dickson, Dennis W. ;
Gauthier, Serge ;
Goldman, Jennifer ;
Goetz, Christopher ;
Korczyn, Amos ;
Lees, Andrew ;
Levy, Richard ;
Litvan, Irene ;
McKeith, Ian ;
Olanow, Warren ;
Poewe, Werner ;
Quinn, Niall ;
Sampaio, Christina ;
Tolosa, Eduardo ;
Dubois, Bruno .
MOVEMENT DISORDERS, 2007, 22 (12) :1689-1707